PL1874761T3 - Pochodne 4H-1,2,4-triazyn-5-onu, ich wytwarzanie i ich zastosowanie jako receptorów nikotynowych acetylocholiny typu a7 - Google Patents
Pochodne 4H-1,2,4-triazyn-5-onu, ich wytwarzanie i ich zastosowanie jako receptorów nikotynowych acetylocholiny typu a7Info
- Publication number
- PL1874761T3 PL1874761T3 PL06755440T PL06755440T PL1874761T3 PL 1874761 T3 PL1874761 T3 PL 1874761T3 PL 06755440 T PL06755440 T PL 06755440T PL 06755440 T PL06755440 T PL 06755440T PL 1874761 T3 PL1874761 T3 PL 1874761T3
- Authority
- PL
- Poland
- Prior art keywords
- triazin
- alpha
- derivatives
- preparation
- nicotinic acetylcholine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D253/075—Two hetero atoms, in positions 3 and 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0504042A FR2884822B1 (fr) | 2005-04-22 | 2005-04-22 | Derives de triazines, leur preparation et leur application en therapeutique |
| EP06755440A EP1874761B1 (fr) | 2005-04-22 | 2006-04-21 | Derives de 4h-1,2,4-triazin-5-0nes, leur preparation et leur utilisation comme des recepteurs a l'acetylcholine de type nicotiniques alpha7 |
| PCT/FR2006/000887 WO2006111662A2 (fr) | 2005-04-22 | 2006-04-21 | Derives de 4h-1 , 2 , 4-triazin-5-0nes , leur preparation et leur utilisation comme des recepteurs a l'acetylcholine de type nicotiniques alpha7 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1874761T3 true PL1874761T3 (pl) | 2011-02-28 |
Family
ID=35219499
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL06755440T PL1874761T3 (pl) | 2005-04-22 | 2006-04-21 | Pochodne 4H-1,2,4-triazyn-5-onu, ich wytwarzanie i ich zastosowanie jako receptorów nikotynowych acetylocholiny typu a7 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US7517881B2 (pl) |
| EP (1) | EP1874761B1 (pl) |
| JP (1) | JP4966295B2 (pl) |
| AR (1) | AR054033A1 (pl) |
| AT (1) | ATE478068T1 (pl) |
| CY (1) | CY1111288T1 (pl) |
| DE (1) | DE602006016258D1 (pl) |
| DK (1) | DK1874761T3 (pl) |
| ES (1) | ES2350950T3 (pl) |
| FR (1) | FR2884822B1 (pl) |
| HR (1) | HRP20100604T1 (pl) |
| PL (1) | PL1874761T3 (pl) |
| PT (1) | PT1874761E (pl) |
| RS (1) | RS51557B (pl) |
| SI (1) | SI1874761T1 (pl) |
| TW (1) | TW200708506A (pl) |
| WO (1) | WO2006111662A2 (pl) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0220581D0 (en) | 2002-09-04 | 2002-10-09 | Novartis Ag | Organic Compound |
| AR049401A1 (es) | 2004-06-18 | 2006-07-26 | Novartis Ag | Aza-biciclononanos |
| GB0415746D0 (en) | 2004-07-14 | 2004-08-18 | Novartis Ag | Organic compounds |
| GB0521508D0 (en) | 2005-10-21 | 2005-11-30 | Novartis Ag | Organic compounds |
| GB0525673D0 (en) | 2005-12-16 | 2006-01-25 | Novartis Ag | Organic compounds |
| GB0525672D0 (en) | 2005-12-16 | 2006-01-25 | Novartis Ag | Organic compounds |
| TWI558398B (zh) | 2009-09-22 | 2016-11-21 | 諾華公司 | 菸鹼乙醯膽鹼受體α７活化劑之用途 |
| KR102472011B1 (ko) * | 2016-05-12 | 2022-11-28 | 버크 인스티튜트 포 리서치 온 에이징 | App 의 정상 가공을 촉진하는 화합물 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4774604B2 (ja) * | 2000-02-14 | 2011-09-14 | 和光純薬工業株式会社 | 第４級アンモニウム塩の製造方法 |
| JP4616971B2 (ja) * | 2000-07-18 | 2011-01-19 | 田辺三菱製薬株式会社 | １−アザビシクロアルカン化合物およびその医薬用途 |
| HUP0402289A2 (hu) * | 2001-10-02 | 2005-02-28 | Pharmacia & Upjohn Company | Gyógyhatású azabiciklusos csoporttal helyettesített kondenzált heteroaril-származékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk |
| SE0301320D0 (sv) * | 2003-05-06 | 2003-05-06 | Astrazeneca Ab | Positive modulators of nicotinic acetylcholine receptors |
-
2005
- 2005-04-22 FR FR0504042A patent/FR2884822B1/fr not_active Expired - Fee Related
-
2006
- 2006-04-20 AR ARP060101561A patent/AR054033A1/es unknown
- 2006-04-21 DK DK06755440.2T patent/DK1874761T3/da active
- 2006-04-21 ES ES06755440T patent/ES2350950T3/es active Active
- 2006-04-21 JP JP2008507128A patent/JP4966295B2/ja not_active Expired - Fee Related
- 2006-04-21 RS RSP-2010/0487A patent/RS51557B/en unknown
- 2006-04-21 EP EP06755440A patent/EP1874761B1/fr active Active
- 2006-04-21 PL PL06755440T patent/PL1874761T3/pl unknown
- 2006-04-21 WO PCT/FR2006/000887 patent/WO2006111662A2/fr active Application Filing
- 2006-04-21 AT AT06755440T patent/ATE478068T1/de active
- 2006-04-21 SI SI200630825T patent/SI1874761T1/sl unknown
- 2006-04-21 DE DE602006016258T patent/DE602006016258D1/de active Active
- 2006-04-21 PT PT06755440T patent/PT1874761E/pt unknown
- 2006-04-21 TW TW095114225A patent/TW200708506A/zh unknown
-
2007
- 2007-10-09 US US11/869,260 patent/US7517881B2/en not_active Expired - Fee Related
-
2010
- 2010-11-10 HR HR20100604T patent/HRP20100604T1/hr unknown
- 2010-11-12 CY CY20101101023T patent/CY1111288T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR2884822B1 (fr) | 2007-06-29 |
| AR054033A1 (es) | 2007-05-30 |
| WO2006111662A3 (fr) | 2006-11-30 |
| EP1874761A2 (fr) | 2008-01-09 |
| US20080096891A1 (en) | 2008-04-24 |
| DK1874761T3 (da) | 2010-12-13 |
| SI1874761T1 (sl) | 2010-12-31 |
| CY1111288T1 (el) | 2015-08-05 |
| JP2008536902A (ja) | 2008-09-11 |
| TW200708506A (en) | 2007-03-01 |
| PT1874761E (pt) | 2010-11-18 |
| US7517881B2 (en) | 2009-04-14 |
| HRP20100604T1 (hr) | 2010-12-31 |
| DE602006016258D1 (de) | 2010-09-30 |
| JP4966295B2 (ja) | 2012-07-04 |
| EP1874761B1 (fr) | 2010-08-18 |
| FR2884822A1 (fr) | 2006-10-27 |
| RS51557B (en) | 2011-06-30 |
| ES2350950T3 (es) | 2011-01-28 |
| WO2006111662A2 (fr) | 2006-10-26 |
| ATE478068T1 (de) | 2010-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200805247B (en) | Quinazoline derivatives, process for their preparation and their use as anti-cancer agents | |
| IL185353A0 (en) | Azabicycloalkane derivatives , pharmaceutical compositions containing the same and methods for the preparation thereof | |
| IL189266A0 (en) | Bicyclo[2.2.1]hept-7-ylamine derivatives and their uses | |
| IL184901A0 (en) | 2,4-diamino-pyridopyrimidine derivatives and their use as mtor inhibitors | |
| HK1093846A2 (en) | Alcohol-free microemulsion composition | |
| IL186188A0 (en) | Pyrimidindione derivatives as prokineticin 2 receptor antagonists | |
| HK1103073A1 (en) | Substituted diaza-spiro-[5.5-undecane derivatives and their use as neurokinin antagonists | |
| IL190754A0 (en) | Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof | |
| IL190423A0 (en) | Selected cgrp antagonists , methods for the production thereof and their use as medicaments | |
| PL1889848T3 (pl) | 6,7-nienasycona-7-karbamoilo-podstawiona pochodna morfinanu | |
| ZA200805354B (en) | Aryl-isoxazol-4-yl-imidazo[1,5-A]pyridine derivatives | |
| IL178461A0 (en) | Substituted 4-alkyl -and 4-alkanoyl-piperidine derivatives and their use as neurokinin antagonists | |
| PL1874761T3 (pl) | Pochodne 4H-1,2,4-triazyn-5-onu, ich wytwarzanie i ich zastosowanie jako receptorów nikotynowych acetylocholiny typu a7 | |
| EP1961753A4 (en) | DERIVATIVES OF PIRAZOLOPYRIMIDINONE, THEIR PREPARATION AND USE | |
| IL189497A0 (en) | Selected cgrp antagonists, methods for the production thereof and their use as medicaments | |
| PL1922309T3 (pl) | Pochodne n-fenylo-2-pirymidynoaminy oraz sposób ich otrzymywania | |
| ZA200706672B (en) | 2,4-Diamino-pyridopyrimidine derivatives and their use as mTOR inhibitors | |
| HUP0500920A2 (en) | Oxadiazole derivatives, process for their preparation and their use | |
| HUP0500921A2 (en) | Tetrazole derivatives, process for their preparation and their use | |
| IL201126A0 (en) | Novel 2,3-benzodiazepine derivatives and their use as antipsychotic agents | |
| IL190334A0 (en) | Pyridylsulfonamide derivatives, their manufacture and use as antineoplastic agents | |
| ZA200803335B (en) | Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof | |
| SI1848731T1 (sl) | Antibiotik 107891, njegovi faktorji, farmacevtsko sprejemljive soli in sestavi, in njihova uporaba | |
| IL188185A0 (en) | Phenylpyridine derivatives, their manufacture and use as pharmaceutical agents | |
| IL190675A0 (en) | Tricyclic lactam derivatives, their manufacture and use as pharmaceutical agents |